Nuformix plc (NFX) Ordinary 0.1p Shares
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Nuformix loss widens as revenue drops
15 July 2021 10:23
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
Company announcements Announcements
-
Result of AGM
19 March 2024 14:39
Nuformix
-
Subscription to raise £150,000
1 March 2024 07:00
Nuformix
-
Posting of Annual Report and Notice of AGM
15 January 2024 11:30
Nuformix
-
Results for the period ended 30 September 2023
3 January 2024 07:00
Nuformix
-
NXP001 Update
18 December 2023 07:00
Nuformix
-
Notice of Allowance of NXP002 Patent in Japan
23 October 2023 07:00
Nuformix
-
NXP001 Update
18 September 2023 07:00
Nuformix
-
Result of Annual General Meeting
24 August 2023 13:22
Nuformix
-
Notice of AGM
31 July 2023 14:00
Nuformix
-
Holding(s) in Company
26 July 2023 14:55
Nuformix
-
Change of Auditor
25 May 2023 07:00
Nuformix
-
Unaudited Interim Report
22 May 2023 07:00
Nuformix
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.